WST
West Pharmaceutical Services insider trading
Health Care · Net selling
Close · Oct 5, 2026
$376.76
+41.0% over 12 months
Share price and insider trades
WST closeInsider buyInsider sale
Bought, 12 months$0
Sold, 12 months$6.6M
Insiders buying0
Insiders selling2
Valuation, profit and volume
P/E (trailing)n/aSector median 24.5
Market value—
Profit margin—Revenue growth —
Volume vs. 50-day0.9×Last 5 sessions
Insiders' paper profit—On all tracked purchases —
Summary
Over the past 12 months, 0 West Pharmaceutical Services insiders reported open-market purchases totaling $0, while 2 insiders reported sales totaling $6.6M. 3 of 8 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales. 48 grants, option exercises and tax withholdings are not shown.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Sep 15SEC | Annette F FavoriteSr. Vp & Chief Hr Officer | Sell Plan | 2,524 | $365.00 | $921K | +3.2% | — |
| Sep 15SEC | Annette F FavoriteSr. Vp & Chief Hr Officer | Sell Plan | 2,500 | $355.00 | $888K | +6.1% | — |
| Sep 15SEC | Annette F FavoriteSr. Vp & Chief Hr Officer | Sell Plan | 2,500 | $345.00 | $862K | +9.2% | — |
| Sep 10SEC | Annette F FavoriteSr. Vp & Chief Hr Officer | Sell | 2,818 | $340.81 | $960K | +10.5% | — |
| Sep 10SEC | Annette F FavoriteSr. Vp & Chief Hr Officer | Sell | 2,817 | $340.81 | $960K | +10.5% | — |
| Sep 10SEC | Annette F FavoriteSr. Vp & Chief Hr Officer | Sell | 2,500 | $340.81 | $852K | +10.5% | — |
| Apr 29SEC | Annette F FavoriteSr. Vp & Chief Hr Officer | Sell | 2,817 | $305.20 | $860K | +23.4% | — |
| Apr 29SEC | Chad WintersVp, Chief Accounting Officer | Sell | 896 | $300.67 | $269K | +25.3% | — |
Insiders at West Pharmaceutical Services
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Annette F FavoriteSr. Vp & Chief Hr Officer | — | $6.3M | Sep 15, 2026 | — |
| Chad WintersVp, Chief Accounting Officer | — | $269K | Apr 29, 2026 | — |
| Robert W. McmahonCFO | — | — | Aug 12, 2026 | — |
| Shane Alden CampbellSvp, Proprietary Segment | — | — | May 14, 2026 | — |
| Mark A ButhmanDirector | — | — | May 6, 2026 | — |
| William F FeeheryDirector | — | — | May 6, 2026 | — |
| Robert F FrielDirector | — | — | May 6, 2026 | — |
| Janet Brutschea HaugenDirector | — | — | May 6, 2026 | — |
| Molly JosephDirector | — | — | May 6, 2026 | — |
| Deborah L KellerDirector | — | — | May 6, 2026 | — |
| Goldman Myla LaiDirector | — | — | May 6, 2026 | — |
| Stephen H LockhartDirector | — | — | May 6, 2026 | — |
| Douglas A MichelsDirector | — | — | May 6, 2026 | — |
| Paolo PucciDirector | — | — | May 6, 2026 | — |
| Rodolphe Jean PoussotSvp, Strategy & Corporate Dev | — | — | Feb 23, 2026 | — |
| Charles WitherspoonVp & Treasurer | — | — | Feb 23, 2026 | — |
| Eric Mark GreenCEO, President | — | — | Feb 19, 2026 | — |
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
Common questions about WST insiders
Are West Pharmaceutical Services insiders buying WST stock?
In the past 12 months, 0 insiders reported open-market purchases of WST worth $0.
Are West Pharmaceutical Services insiders selling WST stock?
2 insiders reported sales worth $6.6M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.